Prostate Cancer Urology
Sep 30, 2024
The following is a summary of “Testosterone Recovery Following Androgen Suppression and Prostate Radiotherapy (TRANSPORT): A Pooled Analysis of Five Randomized Trials from the Meta-Analysis of Rando...
Sep 30, 2024
The following is a summary of “Risk of Biochemical Recurrence and Metastasis in Prostate Cancer Patients Treated with Radical Prostatectomy After a 10-year Disease-free Interval,” published in the...
Sep 27, 2024
The following is a summary of “Intensification Approaches and Treatment Sequencing in Metastatic Castration-resistant Prostate Cancer: A Systematic Review,” published in the September 2024 issue o...
Sep 27, 2024
The following is a summary of “Virtual Reality as an Adjunct to traditional patient counseling in Patients with newly-diagnosed localized prostate cancer,” published in the September 2024 issue of...
Sep 26, 2024
The following is a summary of “American Radium Society Appropriate Use Criteria for the Workup and Treatment of Local Intraprostatic Recurrence of Prostate Cancer Following Definitive Radiotherapy,â...
Sep 26, 2024
The following is a summary of “Incidental Prostate Cancer in Patients Undergoing Surgery for Benign Prostatic Hyperplasia: A Predictive Model,” published in the September 2024 issue of Urology by ...
Sep 24, 2024
The following is a summary of “Natural history of PIRADS-2 lesions on serial multiparametric magnetic resonance imaging: Real-life data from an Academic Center,” published in the September 2024 is...
Sep 24, 2024
The following is a summary of “Salvage local treatment for recurrent prostate cancer after focal therapy: A systematic review and meta-analysis,” published in the September 2024 issue of Urology b...
Sep 20, 2024
The following is a summary of “Liquid Biopsy in Progressing Prostate Cancer Patients Starting Docetaxel with or Without Enzalutamide: A Biomarker Study of the PRESIDE Phase 3b Trial,” published in...
Aug 31, 2024
The following is a summary of “To Hold or Continue Blood Thinners? A Retrospective Analysis on Outcomes of Holmium Laser Enucleation of the Prostate (HoLEP) in Patients who Either Held or Continued ...
May 21, 2024
For patients with locally advanced prostate cancer, neoadjuvant chemohormonal therapy (NCHT) is beneficial for biochemical progression-free survival (bPFS), according to a study published in The Jour...
Mar 05, 2024
Digital rectal examination (DRE) exhibits low diagnostic value as an independent test and supplementary measure to prostate-specific antigen (PSA) for detection of prostate cancer, according to a stud...
Mar 05, 2024
Among patients with prostate cancer, greater consumption of plant-based foods is associated with higher scores in quality-of-life domains, according to a study published in Cancer. Stacy Loeb, MD, PhD...
Feb 12, 2024
Prostate cancer is the most common malignancy in men and remains one of the most prevalent and least understood of all human malignancies. Bladder cancer is the most frequently diagnosed cancer in Chi...
Jan 15, 2024
Some worry that physician practices acquired by private equity may increase the use of services to maximize revenue. We assessed the effects of private equity acquisition on spending, use of treatment...
Jan 05, 2024
At any given prostate-specific antigen (PSA) level, Black men were more likely than White men to develop prostate cancer, according to a study published in Cancer. Kyung Min Lee, PhD, and colleagues p...
Oct 09, 2023
Management of men with advanced prostate cancer has evolved to include urologists, made possible by oral targeted agents (eg, abiraterone or enzalutamide) that can be dispensed directly to patients in...
Aug 03, 2023
Study results indicate that family history of hereditary cancer syndrome appears to increase the risk for prostate cancer progression. Family history (FH) of malignancies, such as breast, ovari...
May 30, 2023
Christopher DiBlasio, MD, board-certified urologist and urologic surgeon, spoke with Physician’s Weekly about PMSA PET, an effective and precise technology for localizing metastatic prostate cancer....
May 08, 2023
We examine changes in the volume of patients with advanced prostate cancer and prescriptions for abiraterone and enzalutamide among urology practices with and without in-office dispensing.Using data f...